Vendor: TRANMOO Peptide 📌 Update — July 10, 2026 TRANMOO has opened a separate promotional offering running from July 10 through July 20. This new promotion overlaps with several products already included in the current Group Buy and adds several additional product options. It is a separate promotion and does not extend every product from the original offering. Products Continuing Through July 20 - Retatrutide 10 mg — $66 - Retatrutide 20 mg — $87 - GHK-Cu 50 mg — $31 - GHK-Cu 100 mg — $35 Original Products Still Closing July 15 - Retatrutide 40 mg — $138 - HGH Frag 5 mg — $115 - Tesamorelin 10 mg — $132 - Ipamorelin 10 mg — $50 Newly Added Products Available Through July 20 - Tirzepatide 10 mg — $52 - Tirzepatide 15 mg — $63 - Tirzepatide 20 mg — $77 - Retatrutide 30 mg — $109 - NAD+ 1000 mg Buffered — $150 - L-Carnitine 1200 mg — $69 - KPV 10 mg — $46 - BB 10 mg — $93 (BPC-157 5mg&TB500(tb4) 5mg - 5-Amino-1MQ 10 mg — $28 - 5-Amino-1MQ 20 mg — $31 - GTT 1500 — $86 (Glutathione 1500mg) All promotional products remain available while supplies last. Products may close early if vendor inventory is exhausted. TRANMOO is also offering a 5% vendor discount if the combined order exceeds $1,000. If that threshold is reached, the applicable discount will be reflected when final participant invoices are calculated. 📅 Original Promotional Products Close: July 15, 2026 📅Continuing and Newly Added Products Close: July 20, 2026 The Dark Horse Consolidated Group Buy allows participants to share and reduce the vendor’s shipping cost. This promotion included a limited number of Certificates of Analysis (COAs) for only a few of the promoted products. I looked for additional supporting documentation, but the available information just was not there. ************************(Most recent available COA PDF attached below.)************** Update July 2nd - Testing disclosure: Tranmoo has confirmed that no COA is currently available for Ipamorelin 10 mg. Participants requesting Ipamorelin have been informed and have chosen to remain in the order.

This TRANMOO Retatrutide promotional opportunity is scheduled to close on July 15. As noted in the original post, this is vendor-promo dependent and could close earlier if inventory sells out or the promotion ends. If anyone is still considering it, please review the original details and reach out before the close date. Current status: 3.5 kits committed. The half kit is hoping for a pairing.

Yesterday we talked about GLOW / KLOW-style blends from the practical side: Convenience versus control. One vial is easier. Fewer pokes. Less handling. Potentially less opportunity for contamination. Separate vials provide more flexibility to adjust the dose of each peptide independently. But there is another layer most beginners never think about: pH balance. That may sound overly technical or just boring, but it matters. A peptide vial is not simply “powder plus water.” Once reconstituted, the peptide is sitting inside a chemical environment. That environment includes: • pH • buffer system • concentration • temperature • time in solution • exposure to oxygen • interaction with other compounds Peptides do not all have the same structure, the same weak points, or the same behavior once they are sitting in liquid. Peptides are chains of amino acids. Those amino acids contain chemical groups that can gain or lose protons depending on the pH of their environment. As a result, a peptide may carry a positive, negative, or neutral electrical charge at a particular pH. Why pH Matters pH can influence how a peptide behaves in solution. Depending on the peptide, an unsuitable environment may increase the chance of: • degradation • aggregation • precipitation • reduced stability • increased irritation • less predictable behavior after reconstitution The Blend Consideration Quickly Forgotten When peptides are kept separate, each vial can exist in its own chemical environment. One peptide may be more stable in one formulation. Another may perform better under different conditions. But when several peptides are blended together, they all have to live in the same vial. That means one shared: • pH • buffer environment • concentration environment • storage condition • reconstituted stability window The question for me is not simply: Do these peptides work well together biologically? The question also becomes: Do these peptides behave well together chemically in the same vial over time?

Think of Cartalax as a structural repair code for your joints and connective tissue. Not a painkiller. Not a temporary anti-inflammatory. Not something designed to simply numb the noise. Cartalax is a short peptide built from just three amino acids connected like three links in a chain: alanine, glutamic acid and aspartic acid. Scientists shorten that exact sequence to Ala–Glu–Asp, or A–E–D. It is the complete three-part chain working as one signal—not three separate ingredients—that gives Cartalax its identity. Cartalax belongs to the Khavinson peptide family, a group of ultra-short bioregulator peptides studied for organ-specific and tissue-specific signaling. In plain English, Cartalax is designed to communicate with connective tissue—especially cartilage cells, bone-forming cells, joint structures and the tissue matrix that helps joints stay strong, cushioned and resilient. It has been studied for its potential role in cartilage support, collagen Type II production, proteoglycan and aggrecan synthesis, joint matrix protection, localized inflammation control and age-related connective tissue function. How Does It Work? The “Joint Blueprint” Effect Cartalax is not about forcing the joint to feel better for a few hours. It is about helping the joint tissue remember how to rebuild, organize and protect itself. Think of your joints like a suspension system. The cartilage is the cushion. The collagen is the framework. The proteoglycans are the shock absorbers. The joint fluid is the lubrication. The bone beneath it is the foundation. The inflammatory signals are the warning lights. Over time, wear and tear, old injuries, repetitive strain, inflammation or aging can start to break that system down. Cartilage can thin. Collagen structure can weaken. Shock absorption can decline. The joint environment can become hot and irritated. Destructive enzymes can start chewing through the matrix faster than the body can repair it. Cartalax is studied as a signal that may help restore order inside that connective tissue environment.

I’m considering whether there is enough interest to organize a traditional Group Buy. To be clear, this would not be a consolidated order and it would not be a rolling threshold model. This would be a standard Group Buy structure: MOQ requirement (Minimum Order Quantity) Specific product list Specific vendor Specific ordering window Specific close date Testing structure stated Before I put any effort into vendor discussions, pricing, or testing options, I’d like to get member feedback first. If the feedback is strong enough, we can pursue it. If interest is very limited, I’ll abandon the concept for now. Two questions: 1. What products would you like to see considered? 2. Is there interest in exploring a traditional Group B format if the right product list comes together? Drop your thoughts below. Product suggestions do not guarantee they will be included, but they will help determine whether this is worth exploring.